PharmaEngine: Clinical Trials

3 completed, 2 terminated, 1 unknown. 6 Phase 2, 2 Phase 1, 1 Phase 3.

By phase and status

Phase	Trials	Status
Phase 2	6	Completed 3, Terminated 2, Unknown 1
Phase 1	2	Terminated 2
Phase 3	1	Completed 1

Follow PharmaEngine: new trials by email

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
A Study of PEP503 With Radiotherapy in Combination With Concurrent Chemotherapy for Patients With Head and Neck Cancer PEP503, Cisplatin, Radiotherapy - Head and Neck Squamous Cell Carcinoma	Phase 1 / Phase 2	Terminated	PharmaEngine	12	2016-10-11	2022-01-11
A Study of PEP503(Radio-enhancer) With Radiotherapy and Chemotherapy for Patients With Rectal Cancer PEP503, 5-fluorouracil, capecitabine - Rectal Cancer	Phase 1 / Phase 2	Terminated	PharmaEngine	32	2015-06-01	2022-01-11
NBTXR3 Crystalline Nanoparticles and Radiation Therapy in Treating Randomized Patients in Two Arms With Soft Tissue Sarcoma of the Extremity and Trunk Wall NBTXR3, Radiation therapy - Adult Soft Tissue Sarcoma	Phase 2 / Phase 3	Completed	Nanobiotix	180	2015-03-03	2021-04-06
Study of PEP02 as a Second Line Therapy for Metastatic Pancreatic Cancer PEP02 - Pancreatic Neoplasms	Phase 2	Completed	PharmaEngine	41	2009-01-01	2019-09-06
Study of PEP02, Irinotecan or Docetaxel in Gastric or Gastroesophageal Junction Adenocarcinoma PEP02, irinotecan, docetaxel - Stomach Neoplasms, Esophageal Neoplasms	Phase 2	Completed	PharmaEngine	135	2007-11-01	2012-03-02
Two-Stage Study to Assess the Efficacy and Safety of 12 Weeks of Treatment With PEP03 in Patients With Chronic Obstructive Pulmonary Disease (COPD) PEP03 - COPD	Phase 2	Unknown	PharmaEngine		2004-09-01	2005-09-22

Conditions studied

Neoplasm Metastasis (2)  ·  Adenocarcinoma (1)  ·  Esophageal Neoplasms (1)  ·  Pancreatic Neoplasms (1)  ·  Pulmonary Disease, Chronic Obstructive (1)  ·  Rectal Neoplasms (1)  ·  Sarcoma (1)  ·  Squamous Cell Carcinoma of Head and Neck (1)  ·  Stomach Neoplasms (1)

Interventions

Radiotherapy (3)  ·  Capecitabine (1)  ·  Cisplatin (1)  ·  Docetaxel (1)  ·  Fluorouracil (1)  ·  Irinotecan (1)

Countries

Taiwan (5)  ·  Spain (2)  ·  Australia (1)  ·  Belgium (1)  ·  Bosnia and Herzegovina (1)  ·  Croatia (1)  ·  France (1)  ·  Germany (1)  ·  Hong Kong (1)  ·  Hungary (1)  ·  Italy (1)  ·  Norway (1)  ·  Philippines (1)  ·  Poland (1)  ·  Romania (1)

Top investigators

Andrew H Ko, M.D. (1)  ·  Cheng-Hsu Wang, M.D. (1)  ·  David Cunningham (1)  ·  Jwa-Yuan Wang, phD (1)  ·  Li-Tzong Chen, M.D. (1)  ·  Yu-Lin Lin, M.D. (1)

Results publications

PMID 19525947, PMID 23406728, PMID 23880820, PMID 31296491, PMID 37166053, PMID 40255171